Selected Start-Ups (4/02)
Executive SummaryIn Vivo briefly summarizes the technologies of these recently founded companies: Accera Inc., Anulex Technologies Inc., Arcanum Discovery Inc., Nanopharma Corp., NiKem Research SRL and Provid Pharmaceuticals Inc.
You may also be interested in...
Company says it has learnt from gene therapy flop Glybera, and claims best-in-class status for viral vector.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.